Taris

Newsroom

News Releases:

TARIS Initiates Phase 2 Clinical Study with LiRIS in Interstitial Cytitis Patients - 11/30/11

TARIS Appoints Christopher Searcy as the Company’s Chief Business Officer - 7/25/11

TARIS Closes $18.3 Million Series B Financing - 4/13/11

TARIS Initiates Clinical Study in Interstitial Cystitis Patients - 3/9/11

TARIS to Present at the 31st Annual SG Cowen Healthcare Conference - 3/1/11

TARIS Appoints Sarma Duddu as President and CEO - 7/19/10

TARIS Successfully Completes Phase 1 Study - 12/2/09

TARIS Appoints Julie Lekstom Himes, MD, to CMO post - 11/06/09

TARIS Biomedical Launches with $15 Million in Funding - 6/24/09

Media Coverage:

TARIS in Forbes Healthcare Blog - 5/26/11

TARIS Bio Taps Third Rock Ventures and Previous Backers in $18.3M Financing Round, Xconomy - 4/14/11

TARIS nets $18.3M funding round, Boston Business Journal - 4/14/11

TARIS Biomedical rounds up $18.3M in Series B financing, Mass High Tech - 4/14/11

TARIS raises $18.3 million in B round, BioCentury Extra - 4/14/11

TARIS Biomedical Takes Aim At Painful Bladder Conditions With $18M, Dow Jones Venture Wire - 4/14/11

Bladder delivery specialist TARIS Biomedical gets $18.3M in Third Rock-led B round, SCRIP - 4/14/11

Start Up Magazine - 9/09

Forbes - 7/21/09

Fierce Biotech - 7/6/09

Medical Device Daily - 6/26/09

TARIS Biomedical raises $15 million - Boston Business Journal - 6/25/09

TARIS Biomedical Launches with $15 Million in Funding to Develop Innovative Drug-Device Therapies - REUTERS - 6/24/09

TARIS Biomedical Gives Glimpse of Drug-Delivery Tech, Discloses $15M Series A, Xconomy, Ryan McBride - Xconomy Boston - 6/9/09

Presentations:

Stay Tuned

Publications:

Stay Tuned